Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03839992 · ClinicalTrials.gov registry record

Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis

A clinical trial of Cystic Fibrosis in Children, sponsored by Gelb, Arthur F., M.D..

Recruiting
Registry status
100
Enrollment target
2
Study locations

NCT03839992 is a study of Cystic Fibrosis in Children that is actively recruiting participants, run by Gelb, Arthur F., M.D.. The registered enrollment target is 100 participants, above the 73-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (37% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03839992, a study of Cystic Fibrosis in Children, is actively recruiting participants, sponsored by Gelb, Arthur F., M.D..

RECRUITING
Registry status
100 participants
Enrollment target
2
Study locations

Study Summary

Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This is a retrospective study.

Interventions

  • DIAGNOSTIC_TEST spirometry

Study Locations (2)

California

  • Arthur F Gelb MD - Lakewood
  • Miller Children's Hospital and Long Beach Medical Center - Long Beach

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-04-25
Est. Completion 2027-11-25

Sponsor

Gelb, Arthur F., M.D.

7 total trials

What the Registry Record Tells You About NCT03839992

The ClinicalTrials.gov registry entry for NCT03839992 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (37% higher). The listed sponsor is Gelb, Arthur F., M.D., which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cystic Fibrosis in Children appearing as the primary indexed condition, and to 1 intervention - of which spirometry is the first listed.

NCT03839992 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03839992 about?

NCT03839992 is a clinical study titled "Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis". Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This is a retrospective study.

What is the current status of trial NCT03839992?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-04-25. Estimated completion is 2027-11-25.

What conditions does trial NCT03839992 study?

This clinical trial studies the following conditions: Cystic Fibrosis in Children.

What interventions are being tested in trial NCT03839992?

The interventions under investigation include: spirometry (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03839992?

This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03839992 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.